BackgroundCheck.run
Search For

David F Fry, 59Meridian, ID

David Fry Phones & Addresses

Meridian, ID   

Morrow, OH   

Mason, OH   

Edison, NJ   

Virginia Beach, VA   

Tacoma, WA   

Blue Ash, OH   

Oak Harbor, WA   

Warren, OH   

Pensacola, FL   

Mentions for David F Fry

Career records & work history

Lawyers & Attorneys

David Fry Photo 1

David Fry - Lawyer

Specialties:
Insurance Law, Personal Injury
ISLN:
902490206
Admitted:
1988
University:
University of Colorado at Denver, B.S., 1985
Law School:
University of Denver, J.D., 1988
David Fry Photo 2

David Fry - Lawyer

Office:
Shaw Keller LLP
Specialties:
Intellectual Property, Commercial
ISLN:
1000711120
Admitted:
2010
Law School:
Duke University School of Law, J.D., 2010
David Fry Photo 3

David Fry - Lawyer

Specialties:
Criminal Law
ISLN:
902490213
Admitted:
1985
University:
Central Missouri State University, B.S.
Law School:
University of Missouri, J.D.

Medicine Doctors

David K. Fry

Specialties:
Pediatrics
Work:
Community Health Service Agency IncPediatric Center Of Greenville
3005 Joe Ramsey Blvd E STE A, Greenville, TX 75401
903-4554458 (phone) 903-4551604 (fax)
Site
Education:
Medical School
Creighton University School of Medicine
Graduated: 1978
Conditions:
Acute Upper Respiratory Tract Infections, Autism, Epilepsy, Otitis Media, Plantar Warts
Languages:
English, Spanish
Description:
Dr. Fry graduated from the Creighton University School of Medicine in 1978. He works in Greenville, TX and specializes in Pediatrics.

License Records

David M Fry

Licenses:
License #: 34197 - Expired
Category: Tow Truck Operator (Consent Tow)
Expiration Date: Mar 30, 2016

David Kent Fry Md

Licenses:
License #: 1001935 - Expired
Category: Pharmacy
Issued Date: Sep 1, 1986
Effective Date: Sep 15, 2010
Expiration Date: Jul 1, 1998
Type: Dispensing Practitioner Pharmacy License

David Kent Fry Md

Licenses:
License #: 14506 - Expired
Category: Medicine
Issued Date: Aug 21, 1978
Effective Date: Sep 14, 2010
Expiration Date: Oct 1, 2010
Type: Physician

David B Fry

Licenses:
License #: RS140094A - Expired
Category: Real Estate Commission
Type: Real Estate Salesperson-Standard

David H Fry Sr

Licenses:
License #: RS115898A - Expired
Category: Real Estate Commission
Type: Real Estate Salesperson-Standard

Publications & IP owners

Us Patents

Neuropeptide-2 Receptor (Y-2R) Agonists And Uses Thereof

US Patent:
7410949, Aug 12, 2008
Filed:
Jan 10, 2006
Appl. No.:
11/328743
Inventors:
Waleed Danho - Wayne NJ, US
George Ehrlich - New York NY, US
David C Fry - Langhorne PA, US
Wajiha Khan - East Hanover NJ, US
Joseph Swistok - Nutley NJ, US
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A61K 38/10
C07K 7/08
US Classification:
514 14, 530327
Abstract:
Provided herein are neuropeptide-2 receptor agonists of the formula (I):Y—R—R—X—R—R—R—R—R—R—R—R—R—R—R—R—NH,   (I)as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity.

Neuropeptide-2 Receptor (Y-2R) Agonists And Uses Thereof

US Patent:
7642244, Jan 5, 2010
Filed:
Dec 1, 2006
Appl. No.:
11/607230
Inventors:
Waleed Danho - Wayne NJ, US
George Ehrlich - New York NY, US
Nader Fotouhi - Basking Ridge NJ, US
David Charles Fry - Langhorne PA, US
Wajiha Khan - East Hanover NJ, US
Anish Konkar - Guttenberg NJ, US
Cristina Martha Rondinone - West Milford NJ, US
Joseph Swistok - Nutley NJ, US
Rebecca Anne Taub - Villanova PA, US
Jefferson Wright Tilley - North Caldwell NJ, US
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A61K 38/10
C07K 7/08
US Classification:
514 13, 514 14, 530326, 930 20
Abstract:
Provided herein are neuropeptide-2 receptor agonists of the formula (I):.

Neuropeptide-2 Receptor (Y-2R) Agonists And Uses Thereof

US Patent:
8268784, Sep 18, 2012
Filed:
Aug 6, 2009
Appl. No.:
12/536688
Inventors:
Waleed Danho - Wayne NJ, US
George Ehrlich - New York NY, US
Nader Fotouhi - Basking Ridge NJ, US
David Charles Fry - Langhorne PA, US
Wajiha Khan - East Hanover NJ, US
Anish Konkar - Guttenberg NJ, US
Cristina Martha Rondinone - West Milford NJ, US
Joseph Swistok - Nutley NJ, US
Rebecca Anne Taub - Villanova PA, US
Jefferson Wright Tilley - North Caldwell NJ, US
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A61K 38/10
C07K 7/08
US Classification:
514 181, 514 52, 514 69, 514 215, 530326, 930 20, 930 30
Abstract:
Provided herein are neuropeptide-2 receptor agonists of the formula (I):.

Neuropeptide-2 Receptor (Y-2R) Agonists

US Patent:
8299023, Oct 30, 2012
Filed:
Aug 25, 2009
Appl. No.:
12/547076
Inventors:
Waleed Danho - Wayne NJ, US
David Charles Fry - Langhorne PA, US
Wajiha Khan - East Hanover NJ, US
Joseph Swistok - Nutley NJ, US
Jefferson Wright Tilley - North Caldwell NJ, US
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A61K 38/10
US Classification:
514 52, 514 215, 530327
Abstract:
Provided herein are neuropeptide-2 receptor agonists of the formula (I):Y—R—R—X—R—R—R—R—R—R—R—R—R—R—R—R—NH  (I) (SEQ ID NO: 1),as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.

Neoropeptide-2-Receptor (Y-2R) Agonists

US Patent:
2010017, Jul 15, 2010
Filed:
Nov 2, 2009
Appl. No.:
12/610417
Inventors:
Waleed Danho - Wayne NJ, US
Nader Fotouhi - Basking Ridge NJ, US
David Charles Fry - Langhorne PA, US
Wajiha Khan - East Hanover NJ, US
Joseph Swistok - Nutley NJ, US
Jefferson Wright Tilley - North Caldwell NJ, US
International Classification:
A61K 38/16
C07K 14/00
C07K 7/00
A61K 38/10
A61P 3/04
A61P 3/10
US Classification:
514 12, 530324, 530326, 514 13
Abstract:
Provided herein are neuropeptide-2 receptor agonists of the formula (I):as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.

Neuropeptide-2 Receptor (Y-2R) Agonists

US Patent:
2011017, Jul 14, 2011
Filed:
Mar 25, 2011
Appl. No.:
13/072048
Inventors:
Karin Conde-Knape - Oberwil, CH
Waleed Danho - Wayne NJ, US
Nader Fotouhi - Basking Ridge NJ, US
David Charles Fry - Langhorne PA, US
Wajiha Khan - East Hanover NJ, US
Anish Konkar - Binningen, CH
Cristina Martha Rondinone - West Milford NJ, US
Joseph Swistok - Nutley NJ, US
Jefferson Wright Tilley - North Caldwell NJ, US
International Classification:
A61K 38/10
C07K 7/08
A61P 3/04
A61P 3/10
US Classification:
514 52, 530326, 514 69
Abstract:
Provided herein are neuropeptide-2 receptor agonists of the formula (I):as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.

Cyclic Growth Hormone Releasing Factor Analogs And Method For The Manufacture Thereof

US Patent:
5084442, Jan 28, 1992
Filed:
Sep 6, 1988
Appl. No.:
7/240662
Inventors:
Arthur M. Felix - West Caldwell NJ
David C. Fry - Langhorne PA
Edgar P. Heimer - Sparta NJ
Vincent S. Madison - Mountain Lakes NJ
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
C07K 700
A61K 3702
US Classification:
514 10
Abstract:
Linear and cyclic Growth Hormone Releasing Factor Analogs and a method for stimulating the release of Growth Hormone in subjects by administering to the subject an effective amount of the compounds of the invention.

Isbn (Books And Publications)

Apple Recipes

Author:
David Fry
ISBN #:
1930354010

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.